Received May 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HBHEPB | HIB + HEP B (COMVAX) | MERCK & CO. INC. | UNK | Y005248 | — |
No additional AE reported.; patient was administered PEDVAXHIB during a temperature excursion.; This spontaneous report was received from an office manager and refers to a(n) patient of unknown age and gender. The patient's medical history, conditions and concomitant therapies were not reported. On 22-Apr-2025, the patient was vaccinated with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB), (lot #Y005248, expiration date: 17-Sep-2026) (1 dose), for prophylaxis, during a temperature excursion. The temperature was 0 degrees Celsius for a time frame of 1 hour. There were no previous temperature excursion. No additional Adverse Event was reported.